Avi Eisbruch
Overview
Explore the profile of Avi Eisbruch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
444
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Medeiros M, The S, Bellile E, Russo N, Schmitd L, Danella E, et al.
Microbiome
. 2023 Dec;
11(1):268.
PMID: 38037123
Background: Oral squamous cell carcinoma (SCC) is associated with oral microbial dysbiosis. In this unique study, we compared pre- to post-treatment salivary microbiome in patients with SCC by 16S rRNA...
2.
Russo N, Bellile E, Murdoch-Kinch C, Liu M, Eisbruch A, Wolf G, et al.
Oral Surg Oral Med Oral Pathol Oral Radiol
. 2016 Aug;
122(4):483-490.e1.
PMID: 27554375
Objective: Approximately one-third of advanced head and neck squamous cell carcinomas (HNSCCs) recur within 2 years of treatment. Due to ease of collection, saliva is of interest to monitor changes...
3.
Mason H, DeRubeis M, Burke N, Shannon M, Karsies D, Wolf G, et al.
World J Clin Oncol
. 2016 Apr;
7(2):220-6.
PMID: 27081644
Patients with locally advanced oropharyngeal cancer are at risk for poor outcomes due to the multi-modal nature of treatment and the potential for treatment-related toxicity. Although treatment with concurrent chemotherapy...
4.
Hoebers F, Yu E, Eisbruch A, Thorstad W, OSullivan B, Dawson L, et al.
Am J Clin Oncol
. 2012 Jan;
36(1):70-6.
PMID: 22237147
Objectives: One of the main normal tissue toxicities in head and neck radiation oncology is xerostomia. In several studies, reduced radiation dose to the salivary glands has been shown to...
5.
6.
Bentzen S, Constine L, Deasy J, Eisbruch A, Jackson A, Marks L, et al.
Int J Radiat Oncol Biol Phys
. 2010 Feb;
76(3 Suppl):S3-9.
PMID: 20171515
Advances in dose-volume/outcome (or normal tissue complication probability, NTCP) modeling since the seminal Emami paper from 1991 are reviewed. There has been some progress with an increasing number of studies...